Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT06216158
Title Iberdomide vs. Iberdomide Plus Isatuximab Maintenance Therapy Post ASCT in Newly Diagnosed Multiple Myeloma
Recruitment Recruiting
Gender both
Phase Phase III
Variant Requirements No
Sponsors University of Heidelberg Medical Center
Age Groups: adult | senior
Covered Countries DEU

No variant requirements are available.